Terms: = Gastric cancer AND GNAS, RP4-543J19_4, 2778, ENSG00000087460, NESP55, NESP, GSP, POH, GNASXL, GNAS1, C20orf45, dJ309F20_1_1, SCG6, GPSA, Gnas, dJ806M20_3_3, XL2, MGC33735, XL, PHP1A, GSA, AHO, XLalphas, PHP1B
30847 results:
1. Clinical value of serum polyunsaturated fatty acids in patients with gastric polyps.
Li N; Qian Q; Ouyang J; Hu M; Liu J; Wu H; Shi R; Zheng S
PeerJ; 2024; 12():e17413. PubMed ID: 38784403
[TBL] [Abstract] [Full Text] [Related]
2. Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in gastric and Gastroesophageal Junction Adenocarcinoma.
Waters R; Sewastjanow-Silva M; Yamashita K; Abdelhakeem A; Iwata KK; Moran D; Elsouda D; Guerrero A; Pizzi M; Vicentini ER; Shanbhag N; Ta A; Chatterjee D; Ajani JA
JCO Precis Oncol; 2024 May; 8():e2300543. PubMed ID: 38781542
[TBL] [Abstract] [Full Text] [Related]
3. [Safety of patients undergoing radical resection combined with paclitaxel-based hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer].
Mei JX; Zhao LY; Zhang WH; Liu K; Chen XL; Yang K; Hu JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):471-477. PubMed ID: 38778687
[No Abstract] [Full Text] [Related]
4. [Clinicopathological features and prognosis of early-onset gastric cancer: a large-scale retrospective real-world study].
Liu JD; Yang CL; Jin PL; Li BS; Zhao JJ; Li HJ; Wang XF; Sun YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):452-456. PubMed ID: 38778684
[No Abstract] [Full Text] [Related]
5. Enhancing surgical outcomes in elderly gastric cancer patients: the role of comprehensive preoperative assessment and support.
Ushimaru Y; Nagano S; Kawabata R; Nishikawa K; Takeoka T; Kitagawa A; Ohara N; Tomihara H; Maeda S; Imasato M; Noura S; Miyamoto A
World J Surg Oncol; 2024 May; 22(1):136. PubMed ID: 38778314
[TBL] [Abstract] [Full Text] [Related]
6. Influence of cachexia on immunotherapy efficacy and prognosis for malignant tumors of the digestive system.
Tao Z; Chen Z; Gao Y; Quan M
Cancer Rep (Hoboken); 2024 May; 7(5):e2100. PubMed ID: 38775250
[TBL] [Abstract] [Full Text] [Related]
7. Clinical biomarkers for thyroid immune-related adverse events in patients with stage III and IV gastrointestinal tumors.
Xing N; Liu J; Hou L; Zhao Y; Ma H; Wang F; Guo Z
Front Immunol; 2024; 15():1381061. PubMed ID: 38774877
[TBL] [Abstract] [Full Text] [Related]
8. Untargeted metabolomics in gastric and colorectal cancer patients - preliminary results.
Kaźmierczak-Siedlecka K; Muszyński D; Styburski D; Makarewicz J; Sobocki BK; Ulasiński P; Połom K; Stachowska E; Skonieczna-Żydecka K; Kalinowski L
Front Cell Infect Microbiol; 2024; 14():1394038. PubMed ID: 38774628
[TBL] [Abstract] [Full Text] [Related]
9. Enhanced multi-class pathology lesion detection in gastric neoplasms using deep learning-based approach and validation.
Kim BS; Kim B; Cho M; Chung H; Ryu JK; Kim S
Sci Rep; 2024 May; 14(1):11527. PubMed ID: 38773274
[TBL] [Abstract] [Full Text] [Related]
10. Stomach cancer Prediction Model (SCoPM): An approach to risk stratification in a diverse U.S. population.
Wu BU; Dong EY; Chen Q; Luong TQ; Lustigova E; Jeon CY; Chen W
PLoS One; 2024; 19(5):e0303153. PubMed ID: 38771811
[TBL] [Abstract] [Full Text] [Related]
11. Evaluating nomogram models for predicting survival outcomes in gastric gastrointestinal stromal tumors with SEER database analysis.
Yong L; Li L; Wu J; Liang P; Gao J
Sci Rep; 2024 May; 14(1):11494. PubMed ID: 38769376
[TBL] [Abstract] [Full Text] [Related]
12. Impact of the number of therapy lines on survival in advanced gastric and esophagogastric adenocarcinoma - a real-world retrospective analysis from Croatia.
Bišof V; Katić A; Soče M; Vidović M; Viculin J; Pleština S; Vrdoljak E
Neoplasma; 2024 Apr; 71(2):201-208. PubMed ID: 38766850
[TBL] [Abstract] [Full Text] [Related]
13. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
14. Genome-wide investigation of lncRNAs revealed their tight association with gastric cancer.
Liu T; Ma Y; Han S; Sun P
J Cancer Res Clin Oncol; 2024 May; 150(5):261. PubMed ID: 38761291
[TBL] [Abstract] [Full Text] [Related]
15. Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
Wang J; Lin J; Wang R; Tong T; Zhao Y
BMC Cancer; 2024 May; 24(1):603. PubMed ID: 38760737
[TBL] [Abstract] [Full Text] [Related]
16. Clip-and-snare method with a pre-looping technique versus conventional method in the treatment of precancerous lesion and early gastric cancer: a retrospective study.
Deng R; Wu J; Li D; Wu B; Shi R; Tian Y; Yao J; Wang LS
BMC Gastroenterol; 2024 May; 24(1):170. PubMed ID: 38760726
[TBL] [Abstract] [Full Text] [Related]
17. Hyponutrition among newly diagnosed gastric cancer.
Pham VT; Nguyen MLT; Pham C; LE QV; Tran DH; LE TS; Nguyen LT; Bui KC
Bratisl Lek Listy; 2024; 125(6):392-398. PubMed ID: 38757598
[TBL] [Abstract] [Full Text] [Related]
18. A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer.
Wu Y; Zhu M; Sun B; Chen Y; Huang Y; Gai J; Li G; Li Y; Wan Y; Ma L
J Nanobiotechnology; 2024 May; 22(1):256. PubMed ID: 38755613
[TBL] [Abstract] [Full Text] [Related]
19. Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants.
De la Torre K; Song M; Abe SK; Rahman MS; Islam MR; Saito E; Min S; Huang D; Chen Y; Gupta PC; Sawada N; Tamakoshi A; Shu XO; Wen W; Sakata R; Kim J; Nagata C; Ito H; Park SK; Shin MH; Pednekar MS; Tsugane S; Kimura T; Gao YT; Cai H; Wada K; Oze I; Shin A; Ahn YO; Ahsan H; Boffetta P; Chia KS; Matsuo K; Qiao YL; Rothman N; Zheng W; Inoue M; Kang D
J Diabetes; 2024 Jun; 16(6):e13561. PubMed ID: 38751364
[TBL] [Abstract] [Full Text] [Related]
20. Implementation of perioperative FLOT compared to ECX/EOX chemotherapy regimens in resectable esophagogastric adenocarcinomas: an analysis of real-world data.
Egebjerg K; Andersen TS; Bæksgaard L; Garbyal R; Siemsen M; Achiam M; Mau-Sørensen PM
Acta Oncol; 2024 May; 63():322-329. PubMed ID: 38745482
[TBL] [Abstract] [Full Text] [Related]
[Next]
